HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >Procedural guidance
  • >Applications for Marketing Authorisation
  • >Advice on specific application types
  • CMDv
    • About CMDv
    • Implementation of the VMP Regulation
    • COVID-19
    • BREXIT
    • Procedural Contact Points
    • Procedural guidance
      • General Information on Applications
      • Validation of Applications
      • Applications for Marketing Authorisation
        • Authorisation procedures
        • Advice on specific application types
        • Clock start dates
      • Post Marketing Procedures
      • CMDv Review Procedure and Referrals
      • Re-examination after DCP/VRA
      • SPC Harmonisation
      • ASMF
      • SPC, Labelling and Package leaflet
      • Miscellaneous
    • Questions & Answers
    • Publications
    • Union Product Database (UPD)
  • VMRI Product Index
  • National Contacts

 

Advice on specific application types

Guidance documents - Regulation (EU) 2019/6

Generics 

Guidance for processing of generic and hybrid applications through MRP / SRP / DCP

Guidance for exchange of documentation relating to reference veterinary medicinal products between Member States

Informed consent

Best practice guide for Informed consent for MRP, SRP and DCP - temporarily removed

Limited markets

Best Practice Guide for handling marketing authorisations for veterinary medicinal products intended for limited markets (national, mutual recognition and decentralised procedures)

Exceptional circumstances

Best Practice Guide for handling applications for marketing authorisations for veterinary medicinal products in exceptional circumstances (national, mutual recognition and decentralised procedures)

Duplicates

Guidance for duplicate applications in mutual recognition and decentralised procedures

 

Guidance documents – Directive 2001/82/EC

Generics 

Guidance for the processing of generic applications through MRP/DCP

Guidance for exchange of documentation relating to a reference veterinary medicinal product between MS

Definition of the term "same medicinal product"

Informed consent

Best practice guide Art. 13(c) informed consent applications

Line extension

Line extensions: Requirements for the content of the dossier - Quality part

Duplicates

Duplicate applications in mutual recognition and decentralised procedures

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. HMA and CMDh/v are in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. In case you notice information that should be updated, please report this website link using the contact form.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/veterinary-medicines/cmdv/procedural-guidance/applications-for-marketing-authorisation/advice-on-specific-application-types.html